» Articles » PMID: 31649623

Cross-Linking/Mass Spectrometry Uncovers Details of Insulin-Like Growth Factor Interaction With Insect Insulin Binding Protein Imp-L2

Overview
Specialty Endocrinology
Date 2019 Oct 26
PMID 31649623
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Structural details of changes accompanying interaction between insulin-related hormones and their binding partners are often enigmatic. Here, cross-linking/mass spectrometry could complement structural techniques and reveal details of these protein-protein interfaces. We used such approach to clarify missing structural description of the interface in human insulin-like growth factor (IGF-1): imaginal morphogenesis protein-late 2 protein (Imp-L2) complex which we studied previously by X-ray crystallography. We crosslinked these proteins by heterobifunctional cross-linker sulfosuccinimidyl 4,4'-azidopentanoate (Sulfo-SDA) for the subsequent mass spectrometry (MS) analysis. The MS analysis revealed IGF-1:Imp-L2 interactions which were not resolved in the crystal structure of this assembly, and they converged with X-ray results, indicating the importance of the IGF-1 N-terminus interaction with the -terminal (185-242) part of the Imp-L2 for stability of this complex. Here, we also showed the advantage and reliability of MS approach in solving details of protein-protein interactions that are too flexible for solid state structural methods.

Citing Articles

The Continuing Evolution of Insulin-like Growth Factor Signaling.

Rosenzweig S F1000Res. 2020; 9.

PMID: 32226608 PMC: 7096212. DOI: 10.12688/f1000research.22198.1.

References
1.
Belfiore A, Malaguarnera R, Vella V, Lawrence M, Sciacca L, Frasca F . Insulin Receptor Isoforms in Physiology and Disease: An Updated View. Endocr Rev. 2017; 38(5):379-431. PMC: 5629070. DOI: 10.1210/er.2017-00073. View

2.
Gotze M, Pettelkau J, Schaks S, Bosse K, Ihling C, Krauth F . StavroX--a software for analyzing crosslinked products in protein interaction studies. J Am Soc Mass Spectrom. 2011; 23(1):76-87. DOI: 10.1007/s13361-011-0261-2. View

3.
Iacobucci C, Sinz A . To Be or Not to Be? Five Guidelines to Avoid Misassignments in Cross-Linking/Mass Spectrometry. Anal Chem. 2017; 89(15):7832-7835. DOI: 10.1021/acs.analchem.7b02316. View

4.
Hwa V, Oh Y, Rosenfeld R . The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999; 20(6):761-87. DOI: 10.1210/edrv.20.6.0382. View

5.
Machackova K, Chrudinova M, Radosavljevic J, Potalitsyn P, Krizkova K, Fabry M . Converting Insulin-like Growth Factors 1 and 2 into High-Affinity Ligands for Insulin Receptor Isoform A by the Introduction of an Evolutionarily Divergent Mutation. Biochemistry. 2018; 57(16):2373-2382. DOI: 10.1021/acs.biochem.7b01260. View